Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02951026 · ClinicalTrials.gov registry record
An Observational Study Evaluating the Safety, Tolerability, and Efficacy of Treatment of SM04690 or Placebo Previously Injected in the Target Knee Joint of Subjects With Moderately to Severely Symptomatic Osteoarthritis
A clinical trial, sponsored by Biosplice Therapeutics.
- Completed
- Registry status
- 703
- Enrollment target
NCT02951026: Completed study, sponsored by Biosplice Therapeutics.
NCT02951026 is a clinical trial that has completed, run by Biosplice Therapeutics. The registered enrollment target is 703 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02951026 has completed, sponsored by Biosplice Therapeutics.
- COMPLETED
- Registry status
- 703 participants
- Enrollment target
Study Summary
This long-term extension study is designed to monitor the long-term safety, tolerability, and efficacy of treatment of SM04690 or placebo previously injected in the target knee joints of subjects with moderately to severely symptomatic osteoarthritis (OA) from a Samumed-sponsored SM04690-OA phase 2 or phase 3 study. No additional SM04690 or placebo therapy will be administered in this study.
Primary Outcome
Compare the incidence rate of SAEs occurring in the (previously injected) SM04690 treatment arms to the (previously injected) placebo treatment arm by Month 60
Interventions
- OTHER Not applicable (no therapy is administered as part of this study)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 703 participants |
| Start Date | 2016-09-19 |
| Est. Completion | 2019-10-31 |
What the finished NCT02951026 record still lists
NCT02951026 is an observational study that tracks outcomes without assigning an intervention. The registered 703 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Not applicable (no therapy is administered as part of this study) is the first listed.
NCT02951026 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02951026 about?
NCT02951026 is a clinical study titled "An Observational Study Evaluating the Safety, Tolerability, and Efficacy of Treatment of SM04690 or Placebo Previously Injected in the Target Knee Joint of Subjects With Moderately to Severely Symptomatic Osteoarthritis". This long-term extension study is designed to monitor the long-term safety, tolerability, and efficacy of treatment of SM04690 or placebo previously injected in the target knee joints of subjects with moderately to severely symptomatic osteoarthritis (OA) from a Samumed-sponsored SM04690-OA phase 2 ...
What is the current status of trial NCT02951026?
This trial is currently completed. The enrollment target is 703 participants. The study started on 2016-09-19. Estimated completion is 2019-10-31.
What interventions are being tested in trial NCT02951026?
The interventions under investigation include: Not applicable (no therapy is administered as part of this study) (OTHER).
Who is sponsoring clinical trial NCT02951026?
This trial is sponsored by Biosplice Therapeutics, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05796687 · 704 participants · NA
Evaluation of My Future Self, an New Teen Pregnancy Prevention Group Intervention for Youth in Non-traditional Settings
- NCT06350734 · 704 participants
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
- NCT06027996 · 702 participants · NA
Melodi Matrix™ in Breast Reconstruction
- NCT06480383 · 705 participants · Phase 2
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI